Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Weiss Michael S
Relationship:   Director
City:   Berkeley Heights
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   16,329,233    

Indirect Shares

   14,546,388      
Direct Value   $216,826,582    

Indirect Value

   $239,124,051      
Total Shares   30,875,621      
Total Value   $455,950,633      


Keryx Biopharmaceuticals Inc $0 Genta Inc De $0 XTL Biopharmaceuticals Ltd $51,000 TG Therapeutics Inc $216,390,075 Fortress Biotech, Inc. $385,507 Avenue Therapeutics, Inc. $0 Keryx Biopharmaceuticals Inc $0 Genta Inc De $0 XTL Biopharmaceuticals Ltd $51,000 TG Therapeutics Inc $216,390,075 Fortress Biotech, Inc. $385,507 Avenue Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    2    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
   -2.8%
 -135.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Keryx Biopharmaceuticals Inc KERX 10% Owner 2010-05-10 1,320,418 2003-11-21 0    Premium*  
            Genta Inc De GNTAQ Director 2005-08-05 537,238 2004-07-14 0    Premium*  
            XTL Biopharmaceuticals Ltd XTLBY Director 2008-08-22 25,000 0    Premium*  
            TG Therapeutics Inc TGTX CEO 2024-01-06 13,074,929 2020-06-22 14,434,214    Premium*  
            Fortress Biotech, Inc. FBIO See Remarks, Director,... 2024-01-01 1,346,985 2013-12-19 0    Premium*  
            Checkpoint Therapeutics, Inc. CKPT Director 2017-06-15 0 2024-05-14 112,174    Premium*  
            Avenue Therapeutics, Inc. ATXI Director 2018-08-07 24,663 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TGTX TG Therapeutics Inc See Remarks   •       •       •   2014-12-16 4 S $16.44 $3,462,560 D/D (210,618) 8,120,773 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2014-12-30 4 A $0.00 $0 D/D 268,603 8,389,376 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2015-06-04 4 A $0.00 $0 D/D 337,257 8,726,633 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2015-12-31 4/A A $0.00 $0 D/D 672,343 9,398,976 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2015-12-31 4 A $0.00 $0 D/D 6,723,443 9,398,976 0 -
TGTX TG Therapeutics Inc See Remarks   •       •       •   2016-09-01 4 GD $0.00 $0 D/D 328,764 9,455,662 0 -
TGTX TG Therapeutics Inc CEO and President   •       •       •   2016-12-30 4 A $0.00 $0 I/I 693,750 10,145,917 0 -
TGTX TG Therapeutics Inc CEO and President   •       •       •   2017-01-01 4 D $0.00 $0 D/D (3,381,866) 6,073,796 0 -
TGTX TG Therapeutics Inc CEO and President   •       •       •   2017-01-01 4 A $0.00 $0 D/D 418,371 9,452,167 0 -
TGTX TG Therapeutics Inc CEO and President   •       •       •   2017-01-01 4 A $0.00 $0 I/I 2,960,000 9,033,796 0 -
TGTX TG Therapeutics Inc CEO and President   •       –      –    2017-06-19 4 GD $0.00 $0 D/D 350,000 9,795,917 0 -
TGTX TG Therapeutics Inc CEO and President   •       –      –    2017-06-19 4 A $0.00 $0 I/I 834,877 10,630,794 0 -
TGTX TG Therapeutics Inc CEO and President   •       –      –    2018-06-26 4 A $0.00 $0 I/I 1,018,011 11,648,805 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2019-06-13 4 A $0.00 $0 I/I 1,179,380 12,828,185 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2019-06-26 4 B $7.04 $351,750 I/I 50,000 12,878,185 0.01 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2020-06-22 4 A $0.00 $0 I/I 1,556,029 14,434,214 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2021-06-18 4 A $0.00 $0 D/D 1,080,770 14,148,852 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2021-12-15 4 GD $0.00 $0 D/D 3,000 14,145,852 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2021-12-16 4 GD $0.00 $0 D/D 709,000 13,436,852 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2021-12-29 4 A $0.00 $0 D/D 56,394 13,493,246 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2022-01-04 4 S $19.20 $720,941 D/D (37,549) 13,455,697 0 %
TGTX TG Therapeutics Inc CEO and President   •       •      –    2022-01-05 4 S $18.31 $561,586 D/D (30,671) 10,988,021 0 %
TGTX TG Therapeutics Inc CEO and President   •       •      –    2023-03-12 4 A $0.00 $0 D/D 985,000 11,973,021 0 -
TGTX TG Therapeutics Inc CEO and President   •       •      –    2023-08-11 4 B $10.13 $1,013,000 D/D 100,000 12,073,021 2.81 %
TGTX TG Therapeutics Inc CEO   •       •      –    2024-01-06 4 A $0.00 $0 D/D 1,001,908 13,074,929 0 -
  126  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us